New Avenues in Male Reproductive Health
Male infertility and male hypogonadism are common reproductive disorders that present in different forms, affecting many aspects of health. However, recent studies have uncovered new ways to improve men's reproductive health. For example, mapping of genetic pathways and novel molecular approaches have allowed us to interrogate mechanisms underlying testicular function which lead to pathology. These may also lead to the development of novel drug therapies to modulate testicular function.
This timely special collection will pull together an array of research focused on improving the treatment of male reproductive disorders. It will cover topics including:
- Genetic disorders in male infertility, including genetics of hypogonadotropic hypogonadism
- Sperm maturation during transport through the male reproductive tract
- Environmental threats for male reproductive health
- Dysregulation of testicular function by obesity or diabetes
- Novel seminal or sperm diagnostic markers of male reproductive function
- Putative therapeutic targets or therapies for male infertility
- Efficacy of treatment with FSH for infertile male patients
- Sperm methylome/transcriptome/proteome and embryo development/offspring health
- Microbiome and reproductive health
- In vitro spermatogenesis.
“This collection has the potential to bring together studies from the latest and most interesting lines of research, promising a better understanding of the causes of male infertility and the identification of new therapeutic approaches.” – Collection editor, Professor Aldo Calogero.
The collection is open to all and welcomes submissions of original research and reviews. Email ec@bioscientifica.com to submit your paper.
This collection has partnered with 'Reproductive Endocrinology 2024' , a new event from the Society for Endocrinology, to offer authors a 10% discount on the event registration fee when submitting an article. To receive the discount code, please email your article title and proposal to ec@bioscientifica.com
The deadline for submissions is 5.00 pm on Friday 28 February 2025.
Read the articles published in the collection:
Testosterone therapy-induced erythrocytosis: can phlebotomy be justified?
Peter Bond, Tijs Verdegaal, and Diederik L Smit
Collection Editors:
Dr. Channa Jayasena – Guest Editor Dr Jayasena is a Reader in Reproductive Endocrinology at Imperial College London, where he currently leads a research team. Dr Jayasena works as a Consultant in Reproductive Endocrinology and Head of Andrology at St. Mary's Hospital and Hammersmith Hospital, London. |
|
Dr. Anu Sironen – Guest Editor Dr. Sironen, University College London (UCL), is currently working on a UK Biotechnology and Biological Sciences Research Council (BBSRC) funded research project to understand the cilia related causes and mechanisms in male infertility. She is a Senior Research Scientist at UCL and Natural Resources Institute Finland, where her studies have identified several genetic causes of male infertility in animal models and in human patients. |
|
Professor Aldo E. Calogero, M.D. – Guest Editor Professor Calogero is a Full Professor of Endocrinology at the University of Catania, Catania, Italy. He is Director of the Division of Endocrinology, Metabolic Diseases and Nutrition of the German University Hospital Policlinico “G. Rodolico – San Marco”, Catania, Italy. |